WM Partners related stories
All articles and analysis
Side Letter: CalSTRS' PE policy changesThe US's second-largest public pension is streamlining its approach to secondaries deals. Plus: why fundless sponsors could be on the rise; and some fund close news. Here's today's brief, for our valued subscribers only.
WM Partners makes three investment team promotionsWM Partners, based in Aventura, Florida, is a middle market firm specializing in buyouts in the health and wellness sector.
WM Partners buys supplements provider Allergy Research GroupThe seller is Kikkoman Corporation.
Japan PE growth sees impact and secondaries momentumAs Japan’s private equity market grows, impact and secondaries strategies gain momentum, and competition for talent intensifies.
Japan’s fund managers slowly warm to GP-led secondariesGP-led activity is picking up thanks to a decline in exit activity during the pandemic and rising familiarity with the practice.
Side Letter: Sequoia's bid to reinvent long-holds; Ares earnings; Banking on Japanese secondariesVenture capital giant Sequoia is undergoing a major restructuring as it embraces longer holds. Plus: What you need to know from Ares' Q3 earnings and why two Japan veterans are banking on the country's secondaries market. Here's today's brief, for our valued subscribers only.
Private equity firms look for new ways to expand their marketingBusiness development is proving to be a key role as market activity heats up.
Highlander's Bettera sold to Catalent for $1bn, Linden makes almost 4.5x its money on recent Flexan saleHighlander sells Bettera to Catalent while Linden generates almost 4.5x return on Flexan,
WM Partners to invest in Raw SugarWM Partners has agreed to invest in Sarasota, Florida-based Raw Sugar LLC, a lifestyle brand.
Firmament and WM Partners backs Ultima Health ProductsFirmament and WM Partners have made an investment in Ultima Health Products, a provider of powdered hydration drink mixes.